Nuvectis Pharma

NVCT

----

主要股东最新
股东
Ron BentsurCo-Founder, Chairman, CEO & President	11.32%	368.84 万	2.54%	+1.25 万	2026/06/30
Charles Mosseri-Marlio	10.12%	329.59 万	2.12%	+5.00 万	2026/06/30
Enrique PoradosuCo-Founder, Executive VP, Chief Scientific & Business Officer	5.54%	180.63 万	1.27%	+0	2026/04/13
Shay ShemeshCo-Founder, Executive VP, Chief Development & Operations Officer	5.50%	179.31 万	1.26%	+0	2026/04/13
Tang Capital Management, LLC	4.76%	155.00 万	--	+155.00 万	2026/06/30
Soleus Capital Management, L.P.	4.60%	149.80 万	0.85%	+49.80 万	2026/08/04
BlackRock, Inc.	3.07%	100.13 万	0.19%	+23.68 万	2026/06/30
Vanguard Capital Management, LLC	3.07%	100.00 万	0.15%	+22.53 万	2026/06/30
Perceptive Advisors LLC	3.07%	100.00 万	--	+100.00 万	2026/06/30
Iridian Asset Management LLC	2.43%	79.32 万	0.48%	+1.61 万	2026/09/30
Geode Capital Management, LLC	1.33%	43.23 万	0.12%	+4.82 万	2026/06/30
Sphera Funds Management Ltd	1.18%	38.29 万	--	+38.29 万	2026/06/30
Baldwin Wealth Partners, LLC	1.17%	38.20 万	0.26%	+0	2026/09/30
Occam Crest Management LP	1.10%	35.71 万	0.44%	-5.00 万	2026/06/30
Alyeska Investment Group, L.P.	0.84%	27.50 万	--	+27.50 万	2026/06/30
State Street Investment Management	0.76%	24.82 万	0.13%	+8.17 万	2026/06/30
Michael CarsonVice President of Finance	0.71%	23.01 万	0.04%	+3.00 万	2026/08/03
Susquehanna International Group, LLP	0.67%	21.73 万	0.27%	+11.20 万	2026/06/30
Avidity Partners Management, L.P.	0.61%	20.00 万	--	+20.00 万	2026/06/30
Kenneth HobermanIndependent Director	0.52%	16.81 万	0.01%	+3.50 万	2026/06/11

全部股东